Diane Cornelison
Neurology · Branson, MONPI 1568406791
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 257 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 22.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,493 and has fallen 93.5% since, to $162 in 2024.
Across 257 payments — averaging $17.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supernus Pharmaceuticals, Inc.$1K
- Sanofi$313
- Lilly USA, LLC$298
- Abbott$288
- Neurocrine Biosciences, Inc.$265
- Pfizer$259
- plus $2K from 25 others
What the payments were for
- Food & beverage$4,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 71 | $1,031 |
| Sanofi | 14 | $313 |
| Lilly USA, LLC | 21 | $298 |
| Abbott | 8 | $288 |
| Neurocrine Biosciences, Inc. | 18 | $265 |
| Pfizer | 15 | $259 |
| AstraZeneca(2 entities) | 10 | $240 |
| Collegium Pharmaceutical, Inc. | 14 | $210 |
| AbbVie(2 entities) | 14 | $208 |
| Novartis | 9 | $203 |
| Biogen | 9 | $156 |
| Amgen | 5 | $152 |
| UCB, Inc. | 8 | $141 |
| Portola Pharmaceuticals, LLC | 2 | $128 |
| Teva Pharmaceuticals USA, Inc. | 8 | $120 |
| EMD Serono, Inc. | 2 | $115 |
| Acadia Pharmaceuticals Inc | 5 | $81 |
| Biodelivery Sciences International, Inc. | 6 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $47 |
| Johnson & Johnson | 2 | $35 |
| Boston Scientific | 2 | $29 |
| Adamas Pharmaceuticals, Inc. | 2 | $28 |
| CSL Behring | 1 | $27 |
| Eisai Inc. | 1 | $21 |
| Shionogi Inc | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Piramal Critical Care | 1 | $16 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Stryker | 1 | $14 |
| Sentynl Therapeutics, Inc. | 1 | $14 |
| Kyowa Kirin, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,573 in reported general payments places this provider in the 70th percentile of 381 neurology providers in Missouri.
Other neurology in Branson
- William RosenfeldChesterfield$2.1M
- Barry SingerSaint Louis$1.9M
- Mark TullmanSaint Louis$1.5M
- Curtis SchreiberBolivar$882K
- Robert NaismithSaint Louis$677K
- Daniel MattsonBridgeton$451K
- Siddharth KaulBridgeton$387K
- Barbara GreenChesterfield$352K
- Steven KosaNorth Kansas City$323K
- Seth HepnerBridgeton$285K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.